Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Use and long-term outcomes of implantable cardioverter-defibrillators, 1990 to 2009.

Bradshaw PJ, Stobie P, Briffa T, Hobbs MS.

Am Heart J. 2013 May;165(5):816-22. doi: 10.1016/j.ahj.2013.02.007. Epub 2013 Mar 19.

PMID:
23622920
2.

Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy.

Maron BJ, Spirito P, Ackerman MJ, Casey SA, Semsarian C, Estes NA 3rd, Shannon KM, Ashley EA, Day SM, Pacileo G, Formisano F, Devoto E, Anastasakis A, Bos JM, Woo A, Autore C, Pass RH, Boriani G, Garberich RF, Almquist AK, Russell MW, Boni L, Berger S, Maron MS, Link MS.

J Am Coll Cardiol. 2013 Apr 9;61(14):1527-35. doi: 10.1016/j.jacc.2013.01.037.

3.

Implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy: efficacy and complications of the therapy in long-term follow-up.

Syska P, Przybylski A, Chojnowska L, Lewandowski M, Sterliński M, Maciag A, Gepner K, Pytkowski M, Kowalik I, Maczyńska-Mazuruk R, Ruzyłło W, Szwed H.

J Cardiovasc Electrophysiol. 2010 Aug 1;21(8):883-9. doi: 10.1111/j.1540-8167.2009.01716.x. Epub 2010 Feb 1.

PMID:
20132378
4.
5.
6.
7.

Long-term follow-up of implantable cardioverter-defibrillator for secondary prevention in chagas' heart disease.

Martinelli M, de Siqueira SF, Sternick EB, Rassi A Jr, Costa R, Ramires JA, Kalil Filho R.

Am J Cardiol. 2012 Oct 1;110(7):1040-5. doi: 10.1016/j.amjcard.2012.05.040. Epub 2012 Jun 20.

PMID:
22727179
8.

Influence of the implantable cardioverter/defibrillator on sudden death and total mortality in patients evaluated for cardiac transplantation.

Sweeney MO, Ruskin JN, Garan H, McGovern BA, Guy ML, Torchiana DF, Vlahakes GJ, Newell JB, Semigran MJ, Dec GW.

Circulation. 1995 Dec 1;92(11):3273-81.

9.

Shock occurrence and survival in 241 patients with implantable cardioverter-defibrillator therapy.

Grimm W, Flores BT, Marchlinski FE.

Circulation. 1993 Jun;87(6):1880-8.

PMID:
8504500
10.

Predictors of appropriate implantable cardioverter-defibrillator therapy during long-term follow-up of patients with coronary artery disease.

Blumer J, Wolber T, Hellermann J, Holzmeister J, Binggeli C, Duru F, Brunckhorst C.

Int Heart J. 2009 May;50(3):313-21.

11.

Improved survival in patients with nonischemic advanced heart failure and syncope treated with an implantable cardioverter-defibrillator.

Fonarow GC, Feliciano Z, Boyle NG, Knight L, Woo MA, Moriguchi JD, Laks H, Wiener I.

Am J Cardiol. 2000 Apr 15;85(8):981-5.

PMID:
10760339
12.

[14-year experience with implantable cardioverter/defibrillators: determination of prognosis and discharge behavior].

Vester EG, Dees H, Dobran I, Hennersdorf M, Perings C, Heydthausen M, Winter J, Strauer BE.

Z Kardiol. 2000;89 Suppl 3:194-205. German.

PMID:
10810803
13.

Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study.

Koller MT, Schaer B, Wolbers M, Sticherling C, Bucher HC, Osswald S.

Circulation. 2008 Apr 15;117(15):1918-26. doi: 10.1161/CIRCULATIONAHA.107.742155. Epub 2008 Apr 7.

14.

Preventive effectiveness of implantable cardioverter defibrillator in reducing sudden cardiac death in the Chinese population: a multicenter trial of ICD therapy versus non-ICD therapy.

Hua W, Niu H, Fan X, Ding L, Xu YZ, Wang J, Chen K, Wang F, Zhang S; ICD Study Group.

J Cardiovasc Electrophysiol. 2012 Nov;23 Suppl 1:S5-9. doi: 10.1111/j.1540-8167.2012.02435.x.

PMID:
23140347
15.

Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy.

Elliott PM, Sharma S, Varnava A, Poloniecki J, Rowland E, McKenna WJ.

J Am Coll Cardiol. 1999 May;33(6):1596-601.

16.

Sudden death in implantable cardioverter-defibrillator recipients: clinical context, arrhythmic events and device responses.

Pires LA, Lehmann MH, Steinman RT, Baga JJ, Schuger CD.

J Am Coll Cardiol. 1999 Jan;33(1):24-32.

17.

Survival and appropriate device interventions in recipients of cardioverter defibrillators implanted for the primary versus secondary prevention of sudden cardiac death.

Stockburger M, Krebs A, Nitardy A, Habedank D, Celebi O, Knaus T, Dietz R.

Pacing Clin Electrophysiol. 2009 Mar;32 Suppl 1:S16-20. doi: 10.1111/j.1540-8159.2008.02222.x.

PMID:
19250084
18.

Distinct clinical features in the recipients of the implantable cardioverter defibrillator in Taiwan: a multicenter registry study.

Tsai CT, Huang SK, Lin JL, Lai LP; Taiwan ICD Registry Investigators.

Pacing Clin Electrophysiol. 2003 Nov;26(11):2083-90.

PMID:
14622308
19.

Application of a mortality risk score in a general population of patients with an implantable cardioverter defibrillator (ICD).

Schaer BA, Kühne MS, Blatter D, Osswald S, Sticherling C.

Heart. 2014 Mar;100(6):487-91. doi: 10.1136/heartjnl-2013-305002. Epub 2014 Jan 10. Erratum in: Heart. 2015 Sep;101(17):1434.

PMID:
24415667
20.

Long-term outcome of patients with unexplained syncope treated with an electrophysiologic-guided approach in the implantable cardioverter-defibrillator era.

Mittal S, Iwai S, Stein KM, Markowitz SM, Slotwiner DJ, Lerman BB.

J Am Coll Cardiol. 1999 Oct;34(4):1082-9.

Supplemental Content

Support Center